Home > Hematology & Oncology > Optimizing Antitumor Therapy in Non-Hodgkin Lymphoma With Granulocyte-Macrophage Colony-Stimulating
Optimizing Antitumor Therapy in Non-Hodgkin Lymphoma With Granulocyte-Macrophage Colony-Stimulating (More Info) new
Description: Please join us for a CME dinner program on November 13, 2008 in Beverly Hills presented by Peter McLaughlin, MD and Lauren Pinter-Brown, MD. Learning Objectives: At the conclusion of the program, participants will be able to provide an overview of current treatment strategies for indolent NHL. 1. Understand the use of rituximab in the treatment of indolent NHL. 2. Explain the benefits of combination GM-CSF/rituximab therapy. 3. Review tumor-specific Id-KLH vaccines and their use in combination with GM-CSF. 4. Recognize the benefits of adjunctive GM-CSF in therapies for indolent NHL.
When: to
Location: ,
Price:
Credit Hours:
Certification:
Submitted by: lmcarthurrx
Hits: 0
Added: Mon Oct 27 2008